Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19

Clinical trial NCT04941105 · COMPLETED

Trial details

NCT number: NCT04941105
Sponsor: Collegium Medicum w Bydgoszczy
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Sars-CoV-2 Infection

Start date: 2021-06-01
Primary completion: 2022-05-17
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.